These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1263 related items for PubMed ID: 24137577

  • 1. The role of 18F-FDG PET and 18F-FDG PET/CT in the evaluation of pediatric Hodgkin's lymphoma and non-Hodgkin's lymphoma.
    Qiu L, Chen Y, Wu J.
    Hell J Nucl Med; 2013; 16(3):230-6. PubMed ID: 24137577
    [Abstract] [Full Text] [Related]

  • 2. The role of PET in lymphoma.
    Jhanwar YS, Straus DJ.
    J Nucl Med; 2006 Aug; 47(8):1326-34. PubMed ID: 16883013
    [Abstract] [Full Text] [Related]

  • 3. Comparison of 18F-FDG Pet/CT and CT: diagnosis performance in lymphoma patient after treatment.
    Chiewvit S, Thephamongkhol K, Ubolnuch K, Pooliam J, Phongsawat N, Chiewvit P.
    J Med Assoc Thai; 2014 Jan; 97(1):85-94. PubMed ID: 24701734
    [Abstract] [Full Text] [Related]

  • 4. Discrepancies and priorities in staging and restaging malignant lymphoma by SPET, SPET/CT, PET/CT and PET/MRI.
    Chavdarova LI, Tzonevska AD, Piperkova EN.
    Hell J Nucl Med; 2013 Jan; 16(3):223-9. PubMed ID: 24137584
    [Abstract] [Full Text] [Related]

  • 5. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation.
    Ng SH, Yen TC, Liao CT, Chang JT, Chan SC, Ko SF, Wang HM, Wong HF.
    J Nucl Med; 2005 Jul; 46(7):1136-43. PubMed ID: 16000282
    [Abstract] [Full Text] [Related]

  • 6. The role of 18F-FDG-PET and PET/CT in patients with sarcoidosis: an updated evidence-based review.
    Treglia G, Annunziata S, Sobic-Saranovic D, Bertagna F, Caldarella C, Giovanella L.
    Acad Radiol; 2014 May; 21(5):675-84. PubMed ID: 24703482
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of diffusion-weighted MRI for pretherapeutic assessment and staging of lymphoma: results of a prospective study in 140 patients.
    Mayerhoefer ME, Karanikas G, Kletter K, Prosch H, Kiesewetter B, Skrabs C, Porpaczy E, Weber M, Pinker-Domenig K, Berzaczy D, Hoffmann M, Sillaber C, Jaeger U, Müllauer L, Simonitsch-Klupp I, Dolak W, Gaiger A, Ubl P, Lukas J, Raderer M.
    Clin Cancer Res; 2014 Jun 01; 20(11):2984-93. PubMed ID: 24696320
    [Abstract] [Full Text] [Related]

  • 8. Diffusion-weighted MRI compared to FDG PET/CT for assessment of early treatment response in lymphoma.
    Hagtvedt T, Seierstad T, Lund KV, Løndalen AM, Bogsrud TV, Smith HJ, Geier OM, Holte H, Aaløkken TM.
    Acta Radiol; 2015 Feb 01; 56(2):152-8. PubMed ID: 24585944
    [Abstract] [Full Text] [Related]

  • 9. Feasibility of [18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer.
    Messa C, Ceresoli GL, Rizzo G, Artioli D, Cattaneo M, Castellone P, Gregorc V, Picchio M, Landoni C, Fazio F.
    Q J Nucl Med Mol Imaging; 2005 Sep 01; 49(3):259-66. PubMed ID: 16172572
    [Abstract] [Full Text] [Related]

  • 10. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP, Komar G, Seppänen MP, Dean KI, Minn HR, Kajander SA, Rinta-Kiikka I, Alanen K, Borra RJ, Puolakkainen PA, Nuutila P, Ovaska JT.
    Ann Surg; 2009 Dec 01; 250(6):957-63. PubMed ID: 19687736
    [Abstract] [Full Text] [Related]

  • 11. Pediatric bone sarcoma: diagnostic performance of ¹⁸F-FDG PET/CT versus conventional imaging for initial staging and follow-up.
    Quartuccio N, Fox J, Kuk D, Wexler LH, Baldari S, Cistaro A, Schöder H.
    AJR Am J Roentgenol; 2015 Jan 01; 204(1):153-60. PubMed ID: 25539251
    [Abstract] [Full Text] [Related]

  • 12. FDG-PET in the detection of bone marrow disease in Hodgkin's disease and aggressive non-Hodgkin's lymphoma and its impact on clinical management.
    Pelosi E, Penna D, Deandreis D, Chiappella A, Skanjeti A, Vitolo U, Bisi G.
    Q J Nucl Med Mol Imaging; 2008 Mar 01; 52(1):9-16. PubMed ID: 18235420
    [Abstract] [Full Text] [Related]

  • 13. Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's disease.
    Jerusalem G, Beguin Y, Fassotte MF, Najjar F, Paulus P, Rigo P, Fillet G.
    Haematologica; 2001 Mar 01; 86(3):266-73. PubMed ID: 11255273
    [Abstract] [Full Text] [Related]

  • 14. An evaluation of the predictive value of mid-treatment 18F-FDG-PET/CT scans in pediatric lymphomas and undefined criteria of abnormality in quantitative analysis.
    Zhu HJ, Halkar R, Alavi A, Goris ML.
    Hell J Nucl Med; 2013 Mar 01; 16(3):169-74. PubMed ID: 24137579
    [Abstract] [Full Text] [Related]

  • 15. Drug-induced pneumonitis detected earlier by 18F-FDG-PET than by high-resolution CT: a case report with non-Hodgkin's lymphoma.
    Yamane T, Daimaru O, Ito S, Nagata T, Yoshiya K, Fukaya N, Ito S, Imai T, Uchida H.
    Ann Nucl Med; 2008 Oct 01; 22(8):719-22. PubMed ID: 18982476
    [Abstract] [Full Text] [Related]

  • 16. Position emission tomography with or without computed tomography in the primary staging of Hodgkin's lymphoma.
    Hutchings M, Loft A, Hansen M, Pedersen LM, Berthelsen AK, Keiding S, D'Amore F, Boesen AM, Roemer L, Specht L.
    Haematologica; 2006 Apr 01; 91(4):482-9. PubMed ID: 16585015
    [Abstract] [Full Text] [Related]

  • 17. The role of 18F-FDG PET/CT for initial staging of nasal type natural killer/T-cell lymphoma: a comparison with conventional staging methods.
    Moon SH, Cho SK, Kim WS, Kim SJ, Chan Ahn Y, Choe YS, Lee KH, Kim BT, Choi JY.
    J Nucl Med; 2013 Jul 01; 54(7):1039-44. PubMed ID: 23658217
    [Abstract] [Full Text] [Related]

  • 18. [The value of integrated PET-CT images in 2 lymphoma patients with skeletal localisations].
    Geerts MC, Quarles van Ufford HM, Kramer MH, van Waes PF, de Klerk JM.
    Ned Tijdschr Geneeskd; 2006 Jan 28; 150(4):204-9. PubMed ID: 16471237
    [Abstract] [Full Text] [Related]

  • 19. FDG-PET/CT predicts outcome in patients with aggressive non-Hodgkin's lymphoma and Hodgkin's disease.
    Querellou S, Valette F, Bodet-Milin C, Oudoux A, Carlier T, Harousseau JL, Chatal JF, Couturier O.
    Ann Hematol; 2006 Nov 28; 85(11):759-67. PubMed ID: 16871391
    [Abstract] [Full Text] [Related]

  • 20. Spinal cord involvement secondary to non-Hodgkin's lymphoma identified by ¹⁸F-FDG PET/CT.
    Mapelli P, Vanoli EG, Picchio M, Gianolli L.
    Rev Esp Med Nucl Imagen Mol; 2013 Mar 28; 32(2):125. PubMed ID: 23246137
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 64.